Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Nepafenac

Nepafenac

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of Nepafenac

3 trials tracked of Nepafenac: 3 in phase 3 or 4.

3Trials tracked
3Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 3
  1. Phase 4 A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification Completed
  2. Phase 4 Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery Completed
  3. Phase 4 Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Ofloxacin shows superior relative efficacy for pain control after photorefractive keratectomy
Rheumatology Meta-analysis
Ofloxacin shows superior relative efficacy for pain control after photorefractive keratectomy Topical and systemic drugs help manage pain after eye surgery
This systematic review and network meta-analysis of 2,797 patients evaluated pharmacological strategies for post-photorefractive keratectomy…
New data identifies specific medications that rank highest for managing patient pain following photorefractive keratectomy eye procedures.
Frontiers Aug 11, 2026